NCT05033158View on ClinicalTrials.gov

The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.

NACompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

June 13, 2023

Conditions
Cancer
Interventions
OTHER

Blood sampling

Blood sampling before and after COVID-19 vaccination

Trial Locations (8)

Unknown

University Hospital Antwerp, Edegem

AZ Klina, Brasschaat

AZ Sint Jan, Bruges

UZ Brussel, Brussels

AZ Sint Lucas, Ghent

UZ Gent, Ghent

AZ Groeninge, Kortrijk

AZ Nikolaas, Sint-Niklaas

All Listed Sponsors
collaborator

KomOpTegenKanker (non-profit organization)

UNKNOWN

lead

University Hospital, Antwerp

OTHER

NCT05033158 - The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population. | Biotech Hunter | Biotech Hunter